The Latest in B-Cell Lymphoma ICYMI

First generics for Gilenya approved by FDA

December 6, 2019

The clinical impact of new approvals in sickle cell, MCL

December 6, 2019

Mantle Cell Lymphoma

More phase 3 ubrogepant data published as FDA decision nears

December 4, 2019

SOX11 shows value as diagnostic marker in MCL

December 4, 2019

Acalabrutinib may outperform other targeted therapies in MCL

December 4, 2019

Antibiotic use may increase the risk of Parkinson’s disease

December 3, 2019

Trial finds three drugs equally effective for established status epilepticus

November 27, 2019

‘Remarkable’ seizure-free rates seen with adjunctive cenobamate

November 27, 2019

FDA approves acalabrutinib for CLL, SLL treatment

November 21, 2019

Scalp Psoriasis Considerations

November 21, 2019

Benefits of focused ultrasound thalamotomy for essential tremor persist for 3 years

November 21, 2019

Frontline ibrutinib saves money over chemoimmunotherapy

November 20, 2019

Rituximab maintenance has a durable benefit in follicular lymphoma

November 19, 2019

CAR T-cell ‘cocktail’ may overcome antigen escape relapse

November 18, 2019

B Cell Lymphoma

Adding polatuzumab extends survival in relapsed/refractory DLBCL

November 16, 2019